FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to arthrology, and can be used for treating cartilage involvement. That is ensured by administering compound FGF-18 at least 3 times during the course of treatment, wherein said administrations are separated by 2 weeks.
EFFECT: invention reduces inflammation in treating cartilage involvement.
16 cl, 9 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2691946C2 |
| IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
| FGF-18 IN TRANSPLANTATION AND TISSUE ENGINEERING PROCEDURES | 2015 |
|
RU2682159C2 |
| COMBINED COMPOSITION CONTAINING FGF-18 COMPOUND | 2016 |
|
RU2745453C2 |
| FGF-18 COMPOSITION IN XYLOGLUCAN GELS | 2014 |
|
RU2695343C2 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| COMPOSITION FOR PREVENTION, RELIEF, OR TREATMENT OF DISEASES OR SYMPTOMS RELATED TO CARTILAGES, INCLUDING HAPLN1 | 2019 |
|
RU2788162C2 |
| TREATING PATHOLOGICAL CONDITIONS OF JOINTS | 2015 |
|
RU2736513C2 |
| INJECTION COMPOSITION OF POLYDEOXYRIBONUCLEOTIDES FOR TREATING OSTEOARTICULAR DISEASES | 2009 |
|
RU2508115C2 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
